Vascular endothelial growth factor (VEGF), cartilage oligomeric protein (COMP) and matrix metalloproteinase 3 (MMP-3) as serum biomarkers in psoriatic arthritis

Journal Title: International Journal of Business and Management Invention - Year 2017, Vol 6, Issue 7

Abstract

Introduction. Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disorder characterized by axial and peripheral joint involvement as well as extra-articular manifestations such as skin and nail disease, enthesitis, dactylitis, uveitis, etc. Given the broad clinical spectrum, the assessment of the natural course, activity, therapeutic response and prognosis of PsA is difficult. The discovery and implementation of biomarkers would allow personalization of the management of PsA patients. Materials and methods. The serum levels of vascular endothelial growth factor (VEGF), cartilage oligomeric matrix protein (COMP) and matrix metalloproteinase 3 (MMP3) and C-reactive protein were measured in 106 patients with psoriatic arthritis – naive and treated with methotrexate and/or biologics (adalimumab, etanercept, infliximab, ustekinumab). Multiple clinical measures, indices and questionnaires used in PsA were also assessed. Results. Patients with achieved minimal disease activity, CPDAI and PASDAS remission had significantly lower serum VEGF concentrations (619.55 pg / ml vs 430.50 pg / ml, p = 0.009; 489.682 vs. 768.991 pg / ml, p = 0.005; and 459, 72 vs 726, 94 pg / ml, p = 0, 004 respectively). Serum levels of VEGF (rs = 0.327; p = 0.015), COMP (rs = 0.328; p = 0.001) and MMP-3 (rs = 0,213; p = 0,028) positively correlated with СRP. There was also a positive association of VEGF levels with PASI (rs = 0.279; p = 0.004), BSA (rs = 0.225, p = 0.02), PASDAS (rs = 0.269; p = 0.005), CPDAI (rs = 0.213; p = 0.014), HAQ-DI (rs = 0.331; p = 0.001), DLQI (rs = 0.232 p = 0.017) and PsAQoL (rs = 0.256; p = 0.008). Serum COMP levels were positively linked with the swollen joints number (rs = 0.204; p = 0.035), PASI (rs = 0.205; p = 0.034) and BSA (rs = 0.247; p = 0.010). MMP-3 correlated with the number of swollen joints (rs = 0.255; p = 0.008). Conclusion. COMP, MMP-3 and especially VEGF could be used as potential biomarkers in psoriatic arthritis.

Authors and Affiliations

A. Kopchev, S. Monov, D. Kyurkchiev, I. Ivanova, T. Georgiev

Keywords

Related Articles

Adoption and Usage of Sustainable Green Banking Practices: An Empirical Study on Internet Banking in Assam

The most serious problem the human beings facing during the present days is manmade environmental degradation. Hence, there have been continuous endeavors across the globe to measure and mitigate this problem caused by h...

Role of Blue Ocean Strategy (BOS) Implementation in Improving Performance of and Competitive Advantage of Products (Studies on Smis – Small and Medium-Sized Industries in Bali)

The purpose of this research was to understand the process of implementation of the Blue Ocean Strategy (BOS) on SMIs in Bali, the role of the implementation of the BOS to improve product performance, and the implication...

Coordination Failure And Opportunistic Behaviour Results In Climate Chaos

IT IS very much astonishing that no policy or management strategy is forthcoming towards the new theory of climate change. Up to 2030, the living conditions for people will change to the worse, as the social systems face...

The Effect of Cost’s on Profitability an Analysis on Small Manufacturing Businesses

Costing is a major issue or concern for every company. It is very difficult to determine cost as there are different classifications of cost items. Cost of one company varies from cost item of another company. That is wh...

Download PDF file
  • EP ID EP406469
  • DOI -
  • Views 122
  • Downloads 0

How To Cite

A. Kopchev, S. Monov, D. Kyurkchiev, I. Ivanova, T. Georgiev (2017). Vascular endothelial growth factor (VEGF), cartilage oligomeric protein (COMP) and matrix metalloproteinase 3 (MMP-3) as serum biomarkers in psoriatic arthritis. International Journal of Business and Management Invention, 6(7), 8-12. https://europub.co.uk./articles/-A-406469